[Form 4] Enova International, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 filed for Enova International (ENVA) reports a new equity award to CEO & Director David Fisher. On 08/06/2025 Fisher received a non-qualified stock option covering 22,401 common shares at an exercise price of $103.92. The option carries a tandem limited stock appreciation right that can be exercised only within 30 days following a defined Change-in-Control event.

Vesting: the option vests in three equal one-third tranches on Aug 6, 2026 / 2027 / 2028, contingent on continued employment. It expires on 08/06/2032. Following the grant, Fisher now beneficially owns 22,401 derivative securities; no purchases or sales of common shares were disclosed.

The transaction appears to be routine executive compensation rather than an opportunistic trade, modestly strengthening alignment between management and shareholders without creating immediate dilution or signaling directional sentiment.

Positive

• Grant of 22,401 stock options ties CEO compensation to future share performance, fostering shareholder alignment

Negative

• None.

Insights

Executive Compensation Analyst

TL;DR: Routine option grant; neutral impact, aligns CEO incentives without cash outlay.

The 22,401-share option grant represents roughly 0.09% of Enova’s 24.9 m shares outstanding—immaterial from a dilution standpoint. Strike price of $103.92 sits near recent trading highs, indicating the board set performance-contingent targets rather than in-the-money concessions. Three-year ratable vesting promotes retention, while the limited SAR only activates after a Change in Control, protecting shareholders from windfall payouts. Because no open-market buying or selling occurred, the filing offers limited insight into management’s view on valuation. Overall, I classify the event as neutral (rating 0) for investors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fisher David

(Last) (First) (Middle)

C/O ENOVA INTERNATIONAL, INC.

175 W. JACKSON BOULEVARD, SUITE 600

(Street)

CHICAGO IL 60604

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(1)(2)	$103.92	08/06/2025		A		22,401		(3)	08/06/2032	Common stock; par value $0.00001 per share	22,401	$0	22,401	D

Explanation of Responses:

1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

3. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 6, 2026, August 6, 2027 and August 6, 2028.

	/s/ Sean Rahilly, as attorney in fact	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ENVA disclose in its latest Form 4?

CEO David Fisher received 22,401 non-qualified stock options at a $103.92 strike price on 08/06/2025.

How many ENVA shares are covered by the new option grant?

22,401 common shares are underlying the option.

When do the ENVA options granted to CEO David Fisher vest?

They vest in three equal portions on Aug 6, 2026, 2027 and 2028.

What is the exercise price of the newly issued ENVA options?

The strike price is $103.92 per share.

Did the CEO buy or sell ENVA common stock?

No open-market purchases or sales were reported; only an option grant was disclosed.

When do the options expire?

The options expire on 08/06/2032.

Does the filing indicate a directional view on ENVA stock?

Not necessarily; the award is routine compensation rather than a discretionary trade.